Accelerate Diagnostics, Inc. Forecast, price target & analysts
Accelerate Diagnostics, Inc. Target price 2024 - Analyst rating & recommendation
Accelerate Diagnostics, Inc. Classifications & Recommendation:
Accelerate Diagnostics, Inc. Price Target
| Target Price | $1.00 |
| Price | $1.85 |
| Deviation |
45.95%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Accelerate Diagnostics, Inc. price target 2025.
The average Accelerate Diagnostics, Inc. target price is $1.00.
This is
45.95%
register free of charge
|
|
| A rating was issued by 2 analysts: 1 Analysts recommend Accelerate Diagnostics, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Accelerate Diagnostics, Inc. stock has an average upside potential 2025 of
45.95%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 12.06 | 11.90 |
| 5.41% | 1.35% | |
| Net Margin | -1,019.54% | -447.71% |
| 31.37% | 56.09% |
1 Analyst has issued a sales forecast Accelerate Diagnostics, Inc. 2024 . The average Accelerate Diagnostics, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast Accelerate Diagnostics, Inc. 2024 . The average Accelerate Diagnostics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -4.94 | -2.14 |
| 35.09% | 56.68% | |
| P/E | negative | |
| EV/Sales | 7.09 |
1 Analysts have issued a Accelerate Diagnostics, Inc. forecast for earnings per share. The average Accelerate Diagnostics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Accelerate Diagnostics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Accelerate Diagnostics, Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
